Prue Gillian, Czamanski-Cohen Johanna, Kassianos Angelos P, Pilleron Sophie, Ladas Aristea, Akcakaya Can Aysun, Roldán-Jiménez Cristina, Degi Csaba Laszlo, Işcan Gökçe, Arslan Sevban, de Boer Angela G E M, Celebic Aleksandar, Doñate-Martínez Ascensión, Alhambra-Borrás Tamara, Mitrevski Boce, Marzorati Chiara, Pravettoni Gabriella, Grasso Roberto, Nazik Evsen, Pawlowska Ewa, Mucalo Iva, Browne John Patrick, Tripkovic Katica, Vojvodic Katarina, Karekla Maria, Moschofidou Maria, Bayram Sule Biyik, Brandão Tânia, Arndt Volker, Jaswal Poonam, Semerci Remziye, Bozkul Gamze, Sahin Eda, Toygar Ismail, Frountzas Maximos, Martins Rui Miguel, Jefford Michael, Keane Danielle, Hegarty Josephine
Medical Biology Centre, Queens University Belfast School of Nursing and Midwifery, Belfast, UK.
School of Creative Arts Therapies, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
BMJ Open. 2025 Feb 16;15(2):e085456. doi: 10.1136/bmjopen-2024-085456.
Cancer and its treatments can lead to a wide range of side-effects that can persist long after treatments have ended. Across Europe, survivorship care is traditionally hospital-based specialist-led follow-up, leading to gaps in supportive care. Improved screening, diagnosis and treatment increase survival rates. With more individuals living with, through and beyond cancer, the predominance of the hospital-based specialist model is unsustainable, costly and resource-intensive. An understanding of what alternative Models of Care are available and the barriers and facilitators to their implementation is a first step towards enhancing supportive care across the cancer journey. The aim of this scoping review is to source and synthesise information from studies evaluating patient-oriented models of cancer survivorship supportive care for adults in Europe.
The scoping review will be reported in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses-Scoping Review Extension guidelines and will be guided by a six-stage methodological framework. A search strategy has been developed according to the Population, Concept and Context structure and will be applied to seven databases. A targeted search of grey literature will be completed. All identified records will be screened using predefined eligibility criteria by at least two researchers and undergo full-text review for inclusion. Data pertaining to the conceptualisation, evaluation and implementation of sourced Models of Care will be extracted.
As there is no primary data, ethical approval is not required. This review will be conducted as part of the EU COST Action CA21152-Implementation Network Europe for Cancer Survivorship Care. The protocol and subsequent scoping review will be published in a peer-reviewed journal. The Action involves representatives from most countries across Europe which will assist with the dissemination of the work to key stakeholders.
癌症及其治疗可能会导致一系列广泛的副作用，这些副作用在治疗结束后仍可能长期存在。在欧洲，传统上癌症幸存者护理是以医院为基础、由专科医生主导的随访，这导致了支持性护理方面的差距。筛查、诊断和治疗的改善提高了生存率。随着越来越多的人患癌生存、度过癌症期并战胜癌症，以医院为基础的专科模式的主导地位已不可持续，成本高昂且资源密集。了解有哪些可供选择的护理模式以及实施这些模式的障碍和促进因素，是在整个癌症治疗过程中加强支持性护理的第一步。本范围综述的目的是收集和综合来自评估欧洲成人癌症幸存者支持性护理的以患者为导向模式的研究信息。
本范围综述将按照系统评价和Meta分析的首选报告项目——范围综述扩展指南进行报告，并将以一个六阶段的方法框架为指导。已根据人群、概念和背景结构制定了检索策略，并将应用于七个数据库。将完成对灰色文献的定向检索。所有确定的记录将由至少两名研究人员使用预定义的纳入标准进行筛选，并进行全文审查以确定是否纳入。将提取与所收集的护理模式的概念化、评估和实施相关的数据。
由于没有原始数据，无需伦理批准。本综述将作为欧盟成本行动CA21152——欧洲癌症幸存者护理实施网络的一部分进行。方案和后续的范围综述将发表在同行评审期刊上。该行动涉及欧洲大多数国家的代表，这将有助于将这项工作传播给关键利益相关者。
